This result is consistent with the well-established role of KEAP1 mutation in activating the NRF2 pathway [22], as seen in the increased expression levels of most NRF2 target genes in KEAP1-mutated NSCLC cells (Fig. 1E). Here, NFE2L2 is linked to non-small cell lung carcinoma.